Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-01
2006-08-01
Lambkin, Deborah C. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S646000, C514S762000
Reexamination Certificate
active
07084171
ABSTRACT:
The invention provides a method of treating a mammal having, or at risk of, an indication associated with a TGF-beta deficiency comprising administering one or more agents that is effective to elevate the level of TGF-beta. The invention also provides novel compounds that elevate TGF-beta levels, as well as pharmaceutical compositions comprising compounds that elevate TGF-beta levels, and methods for detecting diseases associated with endothelial cell activation.
REFERENCES:
patent: 3634517 (1972-01-01), Palopoli et al.
patent: 4133814 (1979-01-01), Jones et al.
patent: 4230862 (1980-10-01), Suarez et al.
patent: 4239778 (1980-12-01), Venton et al.
patent: 4307111 (1981-12-01), Crawley
patent: 4310523 (1982-01-01), Neumann
patent: 4323707 (1982-04-01), Suarez et al.
patent: 4380635 (1983-04-01), Peters
patent: 4382143 (1983-05-01), Shepherd
patent: 4418068 (1983-11-01), Jones
patent: 4442119 (1984-04-01), Magarian et al.
patent: 4696949 (1987-09-01), Toivola et al.
patent: 4839155 (1989-06-01), McCague
patent: 4879315 (1989-11-01), Magarian et al.
patent: 4973755 (1990-11-01), Grafe et al.
patent: 4990538 (1991-02-01), Harris et al.
patent: 4996225 (1991-02-01), Toivola et al.
patent: 5015666 (1991-05-01), Magarian et al.
patent: 5047431 (1991-09-01), Schickaneder et al.
patent: 5049132 (1991-09-01), Shaffer et al.
patent: 5075321 (1991-12-01), Schreiber
patent: 5098903 (1992-03-01), Magarian et al.
patent: 5189212 (1993-02-01), Ruenitz
patent: 5192525 (1993-03-01), Yang et al.
patent: 5219548 (1993-06-01), Yang et al.
patent: 5254594 (1993-10-01), Niikura et al.
patent: 5280040 (1994-01-01), Labroo et al.
patent: 5389670 (1995-02-01), Fontana
patent: 5391557 (1995-02-01), Cullinan et al.
patent: 5393763 (1995-02-01), Black et al.
patent: 5393785 (1995-02-01), Labrie et al.
patent: 5395842 (1995-03-01), Labrie et al.
patent: 5401730 (1995-03-01), Sauvage et al.
patent: 5409955 (1995-04-01), Bockow et al.
patent: 5411988 (1995-05-01), Bockow et al.
patent: 5418252 (1995-05-01), Williams
patent: 5434166 (1995-07-01), Glasebrook
patent: 5436243 (1995-07-01), Sachs et al.
patent: 5439931 (1995-08-01), Sales
patent: 5439932 (1995-08-01), Cullinan
patent: 5441964 (1995-08-01), Bryant et al.
patent: 5441966 (1995-08-01), Dodge
patent: 5441986 (1995-08-01), Thompson
patent: 5445941 (1995-08-01), Yang
patent: 5446053 (1995-08-01), Keohane
patent: 5446070 (1995-08-01), Mantelle
patent: 5447941 (1995-09-01), Zuckerman
patent: 5451589 (1995-09-01), Dodge
patent: 5451590 (1995-09-01), Dodge
patent: 5451603 (1995-09-01), Piggott
patent: 5455275 (1995-10-01), Fontana
patent: 5457116 (1995-10-01), Black et al.
patent: 5457117 (1995-10-01), Black et al.
patent: 5461064 (1995-10-01), Cullinan
patent: 5461065 (1995-10-01), Black et al.
patent: 5462949 (1995-10-01), Jones et al.
patent: 5462950 (1995-10-01), Fontana
patent: 5466810 (1995-11-01), Godfrey
patent: 5480888 (1996-01-01), Kodama et al.
patent: 5480903 (1996-01-01), Piggott et al.
patent: 5480904 (1996-01-01), Bryant et al.
patent: 5482949 (1996-01-01), Black et al.
patent: 5482950 (1996-01-01), Bryant et al.
patent: 5484797 (1996-01-01), Bryant et al.
patent: 5484808 (1996-01-01), Grinnell et al.
patent: 5489587 (1996-02-01), Fontana
patent: 5491159 (1996-02-01), Malamas
patent: 5491173 (1996-02-01), Toivola et al.
patent: 5492927 (1996-02-01), Gitter et al.
patent: 5496828 (1996-03-01), Cullinan
patent: 5496851 (1996-03-01), Grinnell
patent: 5510370 (1996-04-01), Hock et al.
patent: 5521198 (1996-05-01), Zuckerman
patent: 5534527 (1996-07-01), Black et al.
patent: 5552415 (1996-09-01), May
patent: 5563054 (1996-10-01), Briggs et al.
patent: 5571808 (1996-11-01), Leeds
patent: 5604204 (1997-02-01), Ammann et al.
patent: 5605700 (1997-02-01), DeGregorio et al.
patent: 5616608 (1997-04-01), Kinsella et al.
patent: 5652259 (1997-07-01), May
patent: 5658927 (1997-08-01), Magarian et al.
patent: 5658951 (1997-08-01), Magarian et al.
patent: 5660873 (1997-08-01), Nikolaychik et al.
patent: 5686476 (1997-11-01), May
patent: 5693607 (1997-12-01), Segarini et al.
patent: 5716981 (1998-02-01), Hunter et al.
patent: 5719191 (1998-02-01), Maclean et al.
patent: 5731200 (1998-03-01), Ichijo et al.
patent: 5733925 (1998-03-01), Kunz et al.
patent: 5770609 (1998-06-01), Grainger et al.
patent: 5847007 (1998-12-01), Grainger et al.
patent: 5856342 (1999-01-01), Eek
patent: 5912006 (1999-06-01), Bockow et al.
patent: 6117911 (2000-09-01), Grainger et al.
patent: 6410587 (2002-06-01), Grainger et al.
patent: 4320896 (1995-01-01), None
patent: 4320898 (1995-01-01), None
patent: 0095875 (1983-12-01), None
patent: 0260066 (1988-03-01), None
patent: 0377526 (1990-07-01), None
patent: 0584952 (1994-03-01), None
patent: 0629697 (1994-12-01), None
patent: 0659413 (1995-06-01), None
patent: 0659415 (1995-06-01), None
patent: 0659418 (1995-06-01), None
patent: 0659419 (1995-06-01), None
patent: 0659429 (1995-06-01), None
patent: 0664122 (1995-07-01), None
patent: 0664123 (1995-07-01), None
patent: 0664124 (1995-07-01), None
patent: 0664125 (1995-07-01), None
patent: 0665015 (1995-08-01), None
patent: 0668075 (1995-08-01), None
patent: 0670162 (1995-09-01), None
patent: 0675103 (1995-10-01), None
patent: 0675121 (1995-10-01), None
patent: 0684259 (1995-11-01), None
patent: 0699673 (1996-03-01), None
patent: 1015787 (1966-01-01), None
patent: 2273873 (1994-06-01), None
patent: 92/06068 (1992-04-01), None
patent: 93/11757 (1993-06-01), None
patent: 93/19746 (1993-10-01), None
patent: 94/09764 (1994-05-01), None
patent: 94/20098 (1994-09-01), None
patent: 94/20099 (1994-09-01), None
patent: 94/23068 (1994-10-01), None
patent: 95/04544 (1995-02-01), None
patent: 95/17095 (1995-06-01), None
patent: 95/17905 (1995-06-01), None
patent: 96/07402 (1996-03-01), None
patent: 96/21442 (1996-07-01), None
patent: 96/24356 (1996-08-01), None
patent: 96/40098 (1996-12-01), None
Protest Under 37 CFR §1.291(a) Against U.S. Appl. No. 10/170,971, U.S. Appl. No. 09/057,323, U.S. Appl. No. 09/567,558, pp. 1-11, PTO Form 1449 pp. 1-2. (Filed Mar. 2004).
Burton, T.M., “Lilly Osteoporosis Treatment Shows Promise”, The Wall Street Journal, p. A3, A6, (Jun. 6, 1997).
Wiseman, L.R., et al., “Toremifene—A Review of its Pharmacological Properties and Clinical Efficacy in the Management of Advanced Breast Cancer”, Drugs, 54, 141-160, (Jul. 1997).
Cunningham, A., et al., “A Study of the Structural Basis of the Carcinogenicity of Tamoxifen, Toremifene and their Metabolites”, Mutation Research, 349, 85-94, (1996).
Hardcastle, I.R., et al., “Homologs of Idoxifene: Variation of Estrogen Receptor Binding and Calmodulin Antagonism with Chain Length”, J. Med. Chem., 39, 999-1004, (1996).
Kellen, J.A., et al., “The Effect of Toremifene on the Expression of Genes in a Rat Mammary Adenocarcinoma”, In Vivo, 10, 511-514, (1996).
Kuramochi, H., “Conformational Studies and Electronic Structures of Tamoxifen and Toremifene and Their Allylic Carbocations Proposed as Reactive Intermediates Leading to DNA Adduct Formation”, J. Med. Chem., 39, 2877-2886, (1996).
Pennisi, E., “Drug's Link to Genes Reveals Estrogen's Many Sides”, Science, 273, 1171, (Aug. 30, 1996).
Moorthy, B., et al., “Tamoxifen Metabolic Activation: Comparison of DNA Adducts Formed by Microsomal and Chemical Activation of Tamoxifen and 4-Hydroxytamoxifen with DNA Adducts Formed in Vivo”, Cancer Research, 56, 53-57, (Jan. 1, 1996).
Sargent, L.M., et al., “Induction of Hepatic Aneuploidy in Vivo by Tamoxifen, Toremifene and Idoxifene in Female Sprague-Dawley Rats”, Carcinogenesis, 17, 1051-1056, (1996).
Yang, N.N., et al., “Identification of an Estrogen Response Element Activated by Metabolites of 17Beta-Estradiol and Raloxifene”, Science, 273, 1222-1225, (Oct. 30, 1996).
Chandrasekar, B., et al., “Dietary Omega-3 Lipids Delay the Onset and Progression of Autoimmune Lupus Nephritis by Inhibiting Transforming Growth Factor Beta mRNA and Protein Expression”, Journal of Autoimmunity, 8,
Grainger David J.
Kasina Sudhakar
Metcalfe James C.
Baker & Botts LLP
Lambkin Deborah C.
NeoRx Corporation
LandOfFree
Compounds and therapies for the prevention of vascular and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and therapies for the prevention of vascular and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and therapies for the prevention of vascular and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3620993